Endo International (ENDP) is set to acquire Auxilium Pharmaceuticals, Inc (AUXL) for $2.6 billion ($33.25 per share) in cash as well as stock. The transaction is expected to close by the first half of 2015. The acquisition is expected to be immediately accretive to Endo’s earnings following the closure. Auxilium Pharma grabbed Endo’s offer, which represented a huge premium of 55% over Auxilium Pharma’s Sep … Continue reading Biotech Stock in News: Endo to Buy Auxilium & Diversify Portfolio

Good news flowed in at Gilead Sciences (GILD) with the FDA approving the company’s Harvoni for treating patients affected with chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is a once-daily combination treatment of Gilead’s highly successful HCV drug Sovaldi (sofosbuvir 400 mg) and ledipasvir (a NS5A inhibitor 90 mg). Following the FDA approval, Harvoni becomes the first single tablet regimen to treat HCV … Continue reading Biotech Stock News: Gilead Inc Gets Another Major Boost

For those willing to endure the inevitable price roller coaster, there’s tremendous opportunity in hyper-growth biotech stocks. But you have to pick the best stocks if you’re going to generate market-beating returns. So we have considered a simple question: “What is the best biotech stock for your portfolio?” Read below for the major picks. If you’re new to biotech and looking for a great growth … Continue reading Biotech Stocks: What Your Portfolio Should Look Like With Biotech Stocks

Little-known medical equipment and biotech companies jumped on Wall Street on Monday, following news that a nurse had become the first person to contract the deadly Ebola virus in the United States. Shares of biotechnology company Ibio Inc , hazmat suits maker Lakeland Industries Inc , and face mask maker Alpha Pro Tech Ltd were all higher near midday. Investors have piled into various companies … Continue reading Biotech Stock in News: A Look at Biotech Stocks Related to Ebola

While the broad-based SPDR S&P Biotech ETF has galloped higher by 20% year-to-date, a number of biotech stocks are wallowing near their 52-week lows. Could there be bargains to be had among this sea of red? With that in mind we three biotech stocks which have a good chance to turn things around; and here’s a quick look at each of them. Looking at their … Continue reading Biotech Stocks in News: Speculating the Best Biotech Stocks in the Market Currently

Last week, companies like Sunesis Pharmaceuticals, Inc (SNSS) and Chimerix, Inc (CMRX) were in the news due to pipeline updates. While Sunesis’ shares slumped on disappointing data, Chimerix made news related to the Ebola virus. Meanwhile, Regeneron’s (REGN) Eylea continues to gain approval for new indications. Sunesis’ shares tanked 78% on news that a pivotal phase III study being conducted on Qinprezo (vosaroxin) and cytarabine … Continue reading Biotech Stock News: A Look At All the Biotech Stocks For the Past Week